{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-006659","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.643841+00:00","generated_at":"2026-05-25T17:24:20.596964+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Grace Therapeutics updates corporate presentation with cash and runway guidance","bullets":["Corporate presentation updated as of March 3, 2025; includes cash position and runway guidance.","No specific financial figures (e.g., cash balance, runway duration) are available in the filing excerpt.","Presentation furnished as Exhibit 99.1; further detail not disclosed in the 8-K text."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-006659","json":"https://secwatch.observer/filing/0001140361-25-006659.json","markdown":"https://secwatch.observer/filing/0001140361-25-006659.md","text":"https://secwatch.observer/filing/0001140361-25-006659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000114036125006659/0001140361-25-006659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000114036125006659/ef20044669_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T17:24:20.596964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}